China Health Group Inc. (HKG:8225)

Market Cap	123.42M -17.3%
Revenue (ttm)	31.79M +8.0%
Net Income	-16.65M
EPS	-0.02
Shares Out	995.35M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	80,000
Open	0.1240
Previous Close	0.1240
Day's Range	0.1200 - 0.1240
52-Week Range	0.1200 - 0.1980
Beta	-0.42
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 30, 2026

About China Health Group

China Health Group Inc., an investment holding company, researches and develops drugs, bio drugs, natural drugs, and synthetic drugs in the People’s Republic of China. The company offers contracted pharmaceutical development and clinical research, and post market; and post launch market research, medical science, and medical market services. It also provides hospital management, clinical research and promotion, rehabilitation tourism, and specialty hospital services, as well as Wanquan cloud health services. In addition, the company offers phar...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1998
• Employees: 32
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 8225

Financial Performance

In 2025, China Health Group's revenue was 28.56 million, an increase of 7.98% compared to the previous year's 26.45 million. Losses were -14.96 million, 3.05% more than in 2024.

Financial numbers in CNY